Results 111 to 120 of about 31,226 (229)

In patients with neovascular age-related macular degeneration, physical activity may influence C-reactive protein levels

open access: yesClinical Ophthalmology, 2013
Yousif Subhi, Amardeep Singh, Mads Krüger Falk, Torben Lykke SørensenDepartment of Ophthalmology, Clinical Eye Research Unit, Copenhagen University Hospital Roskilde and the University of Copenhagen, Copenhagen, DenmarkPurpose: Association of
Subhi Y   +3 more
doaj  

Durability and Efficacy of Faricimab in Treatment-Resistant Retinal Edema Utilizing “Real-World” Dosing Regimens

open access: yesJournal of Ophthalmology
Conclusions: In “treatment-resistant” patients receiving anti-VEGF therapy for neovascular age-related macular degeneration or diabetic macular edema, switching to IFI in a “real-world” TAE protocol led to statistically significant improvements in ...
Shravan V. Savant   +7 more
doaj   +1 more source

Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK

open access: yesClinical Ophthalmology, 2008
Sobha Sivaprasad, Nachiketa Acharya, Phil HykinMoorfields Eye Hospital, London, UKAbstract: The pathogenesis of age-related macular degeneration (AMD) is unclear, but it can take either a neovascular/exudative/wet form, characterized by choroidal ...
Sobha Sivaprasad   +2 more
doaj  

Successful treatment of neovascular age-related macular degeneration following single bevacizumab failure using aflibercept in a vitrectomized eye

open access: yesClinical Ophthalmology, 2014
Paul Hahn Duke Eye Center, Duke University Medical Center, Durham, NC, USA Abstract: Intravitreal anti-vascular endothelial growth factor (VEGF) pharmacotherapy in vitrectomized eyes remains a challenge due to the reduced half-life of these agents ...
Hahn P
doaj  

Subretinal fibrosis secondary to neovascular age-related macular degeneration: mechanisms and potential therapeutic targets

open access: yesNeural Regeneration Research
Subretinal fibrosis is the end-stage sequelae of neovascular age-related macular degeneration. It causes local damage to photoreceptors, retinal pigment epithelium, and choroidal vessels, which leads to permanent central vision loss of patients with ...
Jingxiang Zhang   +5 more
doaj   +1 more source

A review of generic preference-based measures of health-related quality of life in visual disorders [PDF]

open access: yes
Purpose: This review examines generic preference based measures and their ability to reflect health related quality of life in patients with visual disorders.
Brazier, J.   +3 more
core  

Inter-observer agreement for spectral- and time-domain optical coherence tomography image grading: a prospective study [PDF]

open access: yes, 2018
The purpose of this study was to compare inter-observer agreement of Stratus™ OCT versus Spectralis™ OCT image grading in patients with neovascular age-related macular degeneration (AMD).
Knecht, Pascal   +4 more
core  

Early SUSVIMO in Neovascular Age-Related Macular Degeneration: Real Word Case Report and Clinical Implications

open access: yesInternational Medical Case Reports Journal
Jakob Pericak,1,2 Eric K Chin,3,4 David RP Almeida2 1State University of New York at Geneseo, Geneseo, NY, USA; 2Erie Retina Research & Center for Advanced Surgical Exploration, Erie, PA, USA; 3Retina Consultants of Southern California, Redlands, CA, USA;
Pericak J, Chin EK, Almeida DRP
doaj  

Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab

open access: yesPharmaceuticals
Our objective was to evaluate changes in patient-reported outcome measures using the NEI-VFQ 25 questionnaire during a treat and extend regimen in naive neovascular Age-Related Macular Degeneration patients, and its correlation with anatomical and ...
Pablo Almuiña-Varela   +9 more
doaj   +1 more source

Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data [PDF]

open access: yes, 2018
Aims To evaluate the cost-effectiveness of Age-Related Eye Disease Study (AREDS) 1 & 2 supplements in patients with either bilateral intermediate age-related macular degeneration, AREDS category 3, or unilateral neovascular age-related macular ...
Agron, E   +7 more
core  

Home - About - Disclaimer - Privacy